Information
GEXVal to Participate in BIO-EUROPE SPRING® (MILAN) 2025

Read more
IR
Series C Round Completed, Securing a Total of JPY 910 Million

GEXVal Inc.February 21, 2025 Series C Extension Round Completed: Achieved Total Series C Funding of JPY 910 Mi […]

Read more
Information
Our pipeline information has been updated

GEXVal Inc.February 14, 2025 Our pipeline information has been updated. Pipeline - GEXVal For further informat […]

Read more
R&D
GEXVal Receives Funding from a Parkinson’s Research Program at The Michael J. Fox Foundation

GEXVal Inc.February 14, 2025 GEXVal Inc. (President & CEO: Juran Kato, PhD; Location: Fujisawa, Kanagawa, […]

Read more
IR
GEXVal Raises JPY 300M and Partners with Alfresa Holdings

GEXVal Inc.January 16, 2025 GEXVal Completes Additional Funding of JPY 300 Million in Series C Extension Round […]

Read more